- Oops!Something went wrong.Please try again later.
"Cheap" is not the same as "bad." These high-quality companies are just fantastic buys right now.
Alibaba Group Holding Ltd. beat earnings estimates Tuesday but fell slightly short of revenue expectations, while also announcing a boost to its buyback program.
The oil giant has pledged more dividend rises and share buybacks of around £720 million a quarter until 2025 as oil prices bounce back.
BP made a profit of $7.8bn in the first six months of 2021, compared to a loss of $21.2bn in the first half of 2020.
(Bloomberg) -- Alibaba Group Holding Ltd. reported revenue that missed estimates, suggesting plans to hike spending in pursuit of growth have yet to gain traction.Revenue for the three months ended June climbed from a year earlier to 205.7 billion yuan ($31.8 billion), compared with the 209.4 billion yuan average of analyst estimates. Net income was 45.1 billion yuan, rebounding from a loss in the previous quarter following the firm’s record antitrust penalty. The company announced it was boosti
Every investor wants an ‘in,’ some hint that will tell exactly what a stock is going to do, and when. The kind of signal that will cut through the market’s noise, and makes sense of the deluge of raw data that every company generates. Multiply that data by 10,000 publicly traded stocks, and you’ll have some idea of just how daunting the markets can be. It’s tempting to follow an expert: a Wall Street analyst, or a trading guru. They all have important contributions to make. But here, we’ll take
In 2019 and 2020, Pfizer's (NYSE:PFE) top-selling product was pneumococcal vaccine Prevnar 13. The COVID-19 vaccine BNT162b2, developed by Pfizer and BioNTech (NASDAQ:BNTX), generated sales of $7.8 billion in the first half of 2021 alone. Pfizer expects the vaccine will rake in $33.5 billion over the entire year.
QuantumScape founder and CEO Jagdeep Singh tells Yahoo Finance Live he is confident in hitting key production timelines.
Ocugen's stock price has soared by more than 260% in 2021, while the S&P 500 is up just 17%. The increase has been fueled by the hope that Covaxin, the COVID-19 vaccine candidate Ocugen is co-developing with India's Bharat Biotech, will lead to significant revenue for the healthcare company. The good news is that results look promising -- Ocugen reported in July that phase 3 results showed Covaxin to be over 93% effective in preventing severely symptomatic cases of COVID-19.
Yahoo Finance’s Ines Ferre reports on the day's trending tickers.
Jay Jacobs, SVP and Head of Research & Strategy at Global X ETFs, joined Yahoo Finance to discuss Square’s acquisition of Afterpay.
How do you define a stock market opportunity? Is it a windfall, a piece of luck, or the result of careful planning, a strategy to make the most of any opening? The savvy investor seeks out the latter, looking for stocks that offer inducements to entry, be it a high upside or a depressed share price or a recent positive analyst review – or better yet, a combination of all three. So there’s a profile. We’ve used the TipRanks database to look up three stocks that fit it – stocks with Strong Buy con
(Bloomberg) -- BP Plc followed its Big Oil peers by increasing dividends and share buybacks as higher crude prices boosted profit.The oil majors -- with the notable exception of Exxon Mobil Corp. -- are raising returns as they express confidence that the worst of the slump caused by the coronavirus pandemic is over. Their goal is to woo investors who are becoming increasingly wary about the future of the fossil fuels in a changing climate.BP will increase its dividend by 4% to 5.46 cents a share
Alibaba's results mirror those of e-commerce giant Amazon.com Inc in the United States, as the easing of pandemic-related restrictions has led to more consumers visiting physical stores rather than ordering online. Core commerce revenue for Alibaba rose about 35% to 180.24 billion yuan in the quarter, compared with estimates of 184.23 billion yuan. Overall, revenue rose about 34% to 205.74 billion yuan ($31.83 billion) in the first quarter ended June 30, below estimates for 209.39 billion yuan, according to IBES data from Refinitiv.
In this article, we discuss the 10 best high short interest stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best High Short Interest Stocks to Buy Now. Stocks with high short interest have dominated the headlines in the finance world for a good […]
GE's turnaround is gaining traction as key businesses improve while the industrial giant continues to shrink its debt load.
The video service unit said on Monday it will launch DirecTv Stream, a platform that will allow its users to get access to streaming services such as Netflix, Amazon.com Inc's Prime Video and HBO Max. The move will boost the TV operator's position, which like its peers, had been losing subscribers to video streaming services such as Netflix, Prime Video and Apple Inc's service that offer award-wining and exclusive shows.
On July 28, Tilray (NASDAQ: TLRY) stock surged by 26% in a single trading day after the company published strong quarterly results -- the first earnings report its $4 billion merger with fellow Canadian pot grower Aphria. Revenue shot up, the company finally turned a profit, and its international expansion has begun to pay off. Tilray desperately needed that good news, as its shares are down almost 50% year to date.
The resurgence of COVID-19 cases in the United States due to the Delta variant and the new guidance from the U.S. Centers for Disease Control and Prevention (CDC) that requires fully vaccinated individuals to wear masks have led companies to change their plans on vaccinations and masking. Last week, major companies including Alphabet Inc's Google, Uber Technologies Inc and Facebook Inc said all their U.S. employees must get vaccinated to step into offices. McDonald's also said that masks were always mandatory for staff and customers who were not vaccinated.
(Bloomberg) -- Sanofi will buy its messenger-RNA development partner Translate Bio Inc. for $3.2 billion as the French drugmaker plays catch-up in deploying the technology behind some of the world’s top-selling Covid-19 vaccines.Sanofi agreed to pay $38 in cash for each of Translate Bio’s shares. While the price is 30% above Monday’s closing price, the company is getting a potential bargain “in a very hot therapeutic area,” said Wimal Kapadia, an analyst at Bernstein.Ordinarily a giant in the va
Clinical-stage biotech Infinity Pharmaceuticals (NASDAQ: INFI) had a big and bright Monday, with its stock closing the session more than 38% higher. The rocket that lifted it was ignited by a prominent investment bank's upgrade, the latest in a series of analyst upgrades for the stock. The newest bull for Infinity is Anupam Rama at JPMorgan Chase unit JPMorgan.